LSV ASSET MANAGEMENT - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
LSV ASSET MANAGEMENT ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$673
-17.1%
22,4000.0%0.00%
-50.0%
Q1 2023$812
-7.4%
22,400
-8.9%
0.00%0.0%
Q4 2022$877
-99.9%
24,6000.0%0.00%0.0%
Q3 2022$833,000
+4.0%
24,600
-11.2%
0.00%0.0%
Q2 2022$801,000
-10.5%
27,7000.0%0.00%0.0%
Q1 2022$895,000
+8.1%
27,700
-2.5%
0.00%
+100.0%
Q4 2021$828,000
-16.5%
28,400
-23.7%
0.00%
-50.0%
Q3 2021$992,000
-83.4%
37,200
-80.8%
0.00%
-80.0%
Q2 2021$5,964,000
-77.8%
193,700
-81.1%
0.01%
-78.3%
Q1 2021$26,816,000
+4.3%
1,024,300
+0.2%
0.05%
-2.1%
Q4 2020$25,711,000
+52.0%
1,021,900
+25.9%
0.05%
+34.3%
Q3 2020$16,917,000
+2.3%
811,800
+16.6%
0.04%
+2.9%
Q2 2020$16,538,000
+31.3%
696,366
-0.6%
0.03%
+13.3%
Q1 2020$12,597,000
-23.2%
700,266
+1.3%
0.03%
+15.4%
Q4 2019$16,399,000
-11.1%
691,366
+3.0%
0.03%
-13.3%
Q3 2019$18,439,000
+2595.8%
671,029
+3141.7%
0.03%
+2900.0%
Q2 2019$684,00020,7000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders